Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | KDM6B | O15054 | 1/20 | 0.44 |
| ▸ | KDM5C | P41229 | 1/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.44 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31345624 | 0.98 | ALDH1A1 (0.49) | ALDH1A1GAAARMAPK1KDM4E | |
| SCHEMBL30800091 | 0.82 | ALDH1A1 (0.54) | ALDH1A1ARMAPK1KDM4EKDM6B | |
| SCHEMBL31538151 | 0.82 | KDM4C (0.38) | ALDH1A1GAAKDM4EKDM4CMAPT | |
| SCHEMBL31116587 | 0.82 | KDM4C (0.38) | ALDH1A1GAAKDM4EKDM6BKDM5C | |
| SCHEMBL23461548 | 0.82 | ALDH1A1 (0.41) | ALDH1A1GAAARMAPK1KDM4E | |
| SCHEMBL3882564 | 0.81 | GABRG2 (0.45) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL3062909 | 0.81 | ALDH1A1 (0.50) | ALDH1A1MAPK1KDM4EMAPTGABRP | |
| SCHEMBL3407841 | 0.80 | ALDH1A1 (0.47) | ALDH1A1MAPTCYP3A4 | |
| SCHEMBL163424 | 0.79 | ALDH1A1 (0.51) | ALDH1A1ARMAPK1KDM4EKDM6B | |
| SCHEMBL131790 | 0.79 | ALDH1A1 (0.51) | ALDH1A1ARMAPK1KDM4EKDM6B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119639330-B | Preparation process of waterproof coating for roads and bridges | 平原县农村公路发展中心 | 2025-06-13 | — | — | CN | claimed |
| CN-119639330-A | Preparation process of waterproof coating for roads and bridges | 平原县农村公路发展中心 | 2025-03-18 | — | — | CN | claimed |
| US-20260144743-A1 | COMPOUNDS | TMEM16A LIMITED (GB) | 2026-05-28 | — | — | US | disclosed |
| US-12637426-B2 | 1-cyano-pyrrolidine compounds as USP30 inhibitors | MISSION THERAPEUTICS LIMITED (GB) | 2026-05-26 | — | — | US | disclosed |
| WO-2026103316-A1 | TETRAHYDROFURAN-FORMAMIDE SODIUM CHANNEL MODULATOR AND USE THEREOF IN MEDICINE | 嘉兴安帝康生物科技有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026098709-A1 | DEUTERATED TETRAHYDROFURAN NAV1.8 INHIBITOR AND USE THEREOF | 广州楷石医药有限公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-3856179-B1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| US-12612383-B2 | Polysubstituted pyrrolidine derivative, preparation method therefor and use thereof | SHANGHAI WENNAI THERAPEUTICS CO., LTD. (CN) | 2026-04-28 | — | — | US | disclosed |
| EP-4003977-B1 | PYRIDINE DERIVATIVES AS CALCIUM-ACTIVATED CHLORIDE CHANNEL MODULATORS | TMEM16A LTD (GB) | 2026-04-15 | — | — | EP | disclosed |
| EP-4714435-A2 | SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4699655-A2 | COMPOUNDS | TMEM16A LIMITED (GB) | 2026-02-25 | — | — | EP | disclosed |
| US-20030114674-A1 | 2-Hydroxy-mutilin carbamate derivatives for antibacterial use | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-06-19 | — | — | US | disclosed |
| EP-1268443-A1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SmithKline Beecham p.l.c. (GB) | 2003-01-02 | — | — | EP | disclosed |
| CN-1374960-A | novel integrin receptor antagonists | BASF AG (DE) | 2002-10-16 | — | — | CN | disclosed |
| CN-1355811-A | Integrain receptor antagaonists | BASF AG (DE) | 2002-06-26 | — | — | CN | disclosed |
| WO-2001074788-A1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SMITHKLINE BEECHAM PLC (GB) | 2001-10-11 | — | — | WO | disclosed |
| US-4746653-A | ANTAGONISTS OF N-METHYL-D-ASPARTATE SENSITIVE EXCITATORY AMINO ACID RECEPTOR; TREATMENT OF MUSCULAR SPASMS, CONVULSIVE DISORDERS AND ANXIETY | CIBA-GEIGY CORPORATION (US) | 1988-05-24 | — | — | US | disclosed |
| EP-0010770-B1 | 4-PYRIDYL UREAS OR THIOUREAS SUBSTITUTED IN POSITION 2, PROCESS FOR THEIR PREPARATION AND PLANT GROWTH REGULANTS CONTAINING THEM | Shudo, Koichi, Prof. Dr. (JP) | 1982-07-07 | — | — | EP | disclosed |
| US-4279639-A | N-(2-Substituted-4-pyridyl)ureas and thioureas as well as plant growth regulators containing same, and method for using compounds as plant growth regulators | Okamoto, Toshihiko (JP) | 1981-07-21 | — | — | US | disclosed |
| EP-0010770-A1 | 4-Pyridyl ureas or thioureas substituted in position 2, process for their preparation and plant growth regulants containing them | Shudo, Koichi, Prof. Dr. (JP) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114674-A1 | 2-Hydroxy-mutilin carbamate derivatives for antibacterial use | MSH6, MSH2, PMS2 | ALDH1A1 1967/4885GAA 798/4885AR 4819/4885 |
| US-20260144743-A1 | COMPOUNDS | CACNA1E, TMEM109, CACNA1C | ALDH1A1 1592/4885GAA 1568/4885AR 1904/4885 |
| US-12637426-B2 | 1-cyano-pyrrolidine compounds as USP30 inhibitors | USP30, USP1, USP10 | ALDH1A1 1185/4885GAA 2633/4885AR 3284/4885 |
| US-12612383-B2 | Polysubstituted pyrrolidine derivative, preparation method therefor and use thereof | SCN8A, SCN11A, TRPV1 | ALDH1A1 2204/4885GAA 3309/4885AR 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.